Highlights and Quick Summary
- Cash and Short Term Investments for the quarter ending June 30, 2023 was $88.6 Million (a -79.4% decrease compared to previous quarter)
- Year-over-year quarterly Cash and Short Term Investments decreased by -63.24%
- Annual Cash and Short Term Investments for 2022 was $643 Million (a 11.5% increase from previous year)
- Annual Cash and Short Term Investments for 2021 was $576 Million (a -7.27% decrease from previous year)
- Annual Cash and Short Term Investments for 2020 was $622 Million (a 269.94% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash and Short Term Investments of Emergent Biosolutions Inc.
Most recent Cash and Short Term Investmentsof EBS including historical data for past 10 years.Interactive Chart of Cash and Short Term Investments of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $88.6 | $430.2 | – | – | – |
| 2022 | $642.6 | $241.0 | $358.3 | $436.0 | $642.6 |
| 2021 | $576.3 | $404.0 | $447.7 | $548.0 | $576.3 |
| 2020 | $621.5 | $415.2 | $269.0 | $181.7 | $621.5 |
| 2019 | $168.0 | $139.4 | $177.6 | $137.4 | $168.0 |
| 2018 | $112.4 | $340.4 | $191.28 | $164.65 | $112.4 |
| 2017 | $179.3 | $342.03 | $315.63 | $270.17 | $179.3 |
| 2016 | $271.51 | $298.93 | $333.4 | $341.02 | $271.51 |
| 2015 | $308.3 | $308.72 | $214.84 | $216.52 | $308.3 |
| 2014 | $280.5 | $242.25 | $168.13 | $160.22 | $280.5 |
| 2013 | $179.34 | $172.56 | $156.24 | $130.24 | $179.34 |
| 2012 | $141.67 | $197.9 | – | – | $141.67 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic